These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27159639)

  • 1. A global survey of adverse event following immunization surveillance systems for pregnant women and their infants.
    Cassidy C; MacDonald NE; Steenbeek A; Ortiz JR; Zuber PL; Top KA
    Hum Vaccin Immunother; 2016 Aug; 12(8):2010-2016. PubMed ID: 27159639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse event following immunization surveillance systems for pregnant women and their infants: a systematic review.
    Cassidy C; MacDonald NE; Steenbeek A; Top KA
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):361-7. PubMed ID: 25683692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2018.
    Clothier HJ; Lawrie J; Lewis G; Russell M; Crawford NW; Buttery JP
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32536336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of adverse events following immunization in China: Past, present, and future.
    Liu D; Wu W; Li K; Xu D; Ye J; Li L; Wang H
    Vaccine; 2015 Jul; 33(32):4041-6. PubMed ID: 25936727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of adverse events following immunization during pregnancy and the newborn period.
    Fulton TR; Narayanan D; Bonhoeffer J; Ortiz JR; Lambach P; Omer SB
    Vaccine; 2015 Nov; 33(47):6453-65. PubMed ID: 26413879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015.
    Lei J; Balakrishnan MR; Gidudu JF; Zuber PLF
    Vaccine; 2018 Mar; 36(12):1577-1582. PubMed ID: 29454518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.
    Joshi J; Das MK; Polpakara D; Aneja S; Agarwal M; Arora NK
    Indian J Pediatr; 2018 Feb; 85(2):139-148. PubMed ID: 29170922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in Immunization Safety Monitoring - Worldwide, 2010-2019.
    Salman O; Topf K; Chandler R; Conklin L
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(15):547-551. PubMed ID: 33857066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of maternal immunization.
    Regan AK
    Hum Vaccin Immunother; 2016 Dec; 12(12):3132-3136. PubMed ID: 27541370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active surveillance for adverse events following immunization.
    Crawford NW; Clothier H; Hodgson K; Selvaraj G; Easton ML; Buttery JP
    Expert Rev Vaccines; 2014 Feb; 13(2):265-76. PubMed ID: 24350637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
    Masuka JT; Khoza S
    BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
    Glover C; Crawford N; Leeb A; Wood N; Macartney K
    Vaccine; 2020 Jun; 38(31):4892-4900. PubMed ID: 32499067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial.
    Nyambayo PPM; Gold MS; Mehta UC; Clarke S; Manyevere R; Chirinda L; Zifamba EN; Nyamandi T
    Vaccine; 2023 Oct; 41(45):6700-6709. PubMed ID: 37805357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.
    Guo B; Page A; Wang H; Taylor R; McIntyre P
    Vaccine; 2013 Jan; 31(4):603-17. PubMed ID: 23200940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI.
    Parrella A; Gold M; Braunack-Mayer A; Baghurst P; Marshall H
    Hum Vaccin Immunother; 2014; 10(3):747-54. PubMed ID: 24406315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.
    Clothier HJ; Hosking L; Crawford NW; Russell M; Easton ML; Quinn JA; Buttery JP
    Drug Saf; 2015 Jan; 38(1):79-86. PubMed ID: 25475539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events following immunization: is this time for the use of WHO causality assessment?
    Tafuri S; Gallone MS; Calabrese G; Germinario C
    Expert Rev Vaccines; 2015 May; 14(5):625-7. PubMed ID: 25805053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine safety surveillance informs public health policy beyond immunization: A case-series on bleeding following vaccination, Nepal, 2016-2018.
    Pradhan R; Sharma Gautam J; Tinkari BS; Adhikari N; Bose AS
    Vaccine; 2020 Sep; 38(40):6320-6326. PubMed ID: 32788134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening of causality assessment of adverse events following immunization in the WHO South East Asia and Western Pacific regions: Lessons from the 2014 SEAR inter-country workshop.
    MacDonald NE; Guichard S; Amarasinghe A; Balakrishnan MR;
    Vaccine; 2015 Nov; 33(48):6902-7. PubMed ID: 25617790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.